CIK: 0001710065
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 63.94% | -84.07% | EXIT | |
| 2 | ✓ | Rallybio CORP | Stock-Other | 18.18% | — | — | |
| 3 | KYMR | Kymera Therapeutics INC | Stock-Other | 6.71% | -5.36% | EXIT | |
| 4 | SEER | Seer INC | Stock-Other | 6.56% | -5.06% | EXIT | |
| 5 | ✓ | Xilio Therapeutics INC | Stock-Other | 1.88% | — | — | |
| 6 | ✓ | Rapt Therapeutics INC | Stock-Other | 1.85% | — | — | |
| 7 | STRO | Sutro Biopharma, Inc. | Stock-Other | 0.89% | -1.43% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Rallybio CORP | +17.9% | — | Unchanged |
| 2 | SEER | Seer INC | +5% | — | Unchanged |
| 3 | ✓ | Rapt Therapeutics INC | +1.6% | — | Unchanged |
| 4 | ✓ | Xilio Therapeutics INC | +1.4% | — | Unchanged |
| 5 | STRO | Sutro Biopharma, Inc. | +0.8% | -90.00% | Trim |
| 6 | ACLXGBX | Arcellx INC | -10.8% | -78.67% | Trim |
| 7 | KYMR | Kymera Therapeutics INC | -15.8% | -95.70% | Trim |